Charité in Berlin said a U.S. citizen treated for Ebola has been discharged after recovering from the Bundibugyo strain contracted in the Democratic Republic of Congo. Reuters and Charité said the patient had tested negative since May 30, while WHO says the outbreak remains active.
Berlin's Charité hospital said it has discharged a U.S. citizen who was treated for Ebola after contracting the Bundibugyo strain in the Democratic Republic of Congo.
Reuters reported on June 6 that the patient had been discharged after about two weeks of treatment in Berlin. Charité said no virus had been detected in the patient since May 30, and the hospital said none of the quarantined family members showed symptoms.
The case is tied to the ongoing Bundibugyo Ebola outbreak in DRC and Uganda, which the World Health Organization has said remains a public health emergency of international concern. WHO and Africa CDC launched a joint continental response plan on June 5 to help contain the outbreak.
Charité said the patient had been admitted to its special isolation ward after being flown to Berlin for high-security treatment. The hospital's statement identified the infection as Bundibugyo virus, one of the strains that can cause Ebola disease.
The discharge is a recovery milestone in an outbreak that is still active. Public-health officials have warned that the wider situation in central Africa continues to require close monitoring and coordinated response efforts.
What happens next
The public record reviewed so far does not confirm whether the patient or family will return to the DRC or remain in Germany. It also does not fully detail the patient's treatment course.
WHO's ongoing response plan and the continuing outbreak in DRC and Uganda mean health authorities are still focused on tracking cases, isolating contacts and preventing further spread.
Revision note
Initial automated publication.